Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Low-dose AgNPs reduce lung mechanical function and innate immune defense in the absence of cellular toxicity.

Botelho DJ, Leo BF, Massa CB, Sarkar S, Tetley TD, Chung KF, Chen S, Ryan MP, Porter AE, Zhang J, Schwander SK, Gow AJ.

Nanotoxicology. 2016;10(1):118-27. doi: 10.3109/17435390.2015.1038330. Epub 2015 Jul 7.

2.

The immunology of tuberculosis: from bench to bedside.

Dheda K, Schwander SK, Zhu B, van Zyl-Smit RN, Zhang Y.

Respirology. 2010 Apr;15(3):433-50. doi: 10.1111/j.1440-1843.2010.01739.x. Review.

3.

Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia.

Nakamura T, Schwander SK, Donnelly R, Ortega F, Togo F, Broderick G, Yamamoto Y, Cherniack NS, Rapoport D, Natelson BH.

Clin Vaccine Immunol. 2010 Apr;17(4):582-7. doi: 10.1128/CVI.00379-09. Epub 2010 Feb 24.

4.

Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.

Juarez E, Nuñez C, Sada E, Ellner JJ, Schwander SK, Torres M.

Respir Res. 2010 Jan 5;11:2. doi: 10.1186/1465-9921-11-2.

5.

Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis.

Herrera MT, Torres M, Nevels D, Perez-Redondo CN, Ellner JJ, Sada E, Schwander SK.

Tuberculosis (Edinb). 2009 Jan;89(1):38-47. doi: 10.1016/j.tube.2008.08.002. Epub 2008 Oct 9.

6.

Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA.

Tang KC, Trzaska KA, Smirnov SV, Kotenko SV, Schwander SK, Ellner JJ, Rameshwar P.

J Immunol. 2008 Feb 1;180(3):1826-33.

7.

Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis.

Saliu OY, Crismale C, Schwander SK, Wallis RS.

J Antimicrob Chemother. 2007 Nov;60(5):994-8. Epub 2007 Aug 29.

PMID:
17761500
8.

Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity.

Saliu OY, Sofer C, Stein DS, Schwander SK, Wallis RS.

J Infect Dis. 2006 Aug 15;194(4):486-92. Epub 2006 Jul 10.

PMID:
16845632
9.

Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts.

Carranza C, Juárez E, Torres M, Ellner JJ, Sada E, Schwander SK.

Am J Respir Crit Care Med. 2006 Jan 15;173(2):238-45. Epub 2005 Oct 6.

10.

Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells.

Rivas-Santiago B, Schwander SK, Sarabia C, Diamond G, Klein-Patel ME, Hernandez-Pando R, Ellner JJ, Sada E.

Infect Immun. 2005 Aug;73(8):4505-11.

11.

Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity.

Janulionis E, Sofer C, Schwander SK, Nevels D, Kreiswirth B, Shashkina E, Wallis RS.

Infect Immun. 2005 May;73(5):2595-601.

12.

Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion.

Mansour A, McCarthy B, Schwander SK, Chang V, Kotenko S, Donepudi S, Lee J, Raveche E.

Cell Cycle. 2004 Dec;3(12):1597-605. Epub 2004 Dec 8.

PMID:
15611648
13.

The species Mycobacterium africanum in the light of new molecular markers.

Niemann S, Kubica T, Bange FC, Adjei O, Browne EN, Chinbuah MA, Diel R, Gyapong J, Horstmann RD, Joloba ML, Meyer CG, Mugerwa RD, Okwera A, Osei I, Owusu-Darbo E, Schwander SK, Rüsch-Gerdes S.

J Clin Microbiol. 2004 Sep;42(9):3958-62.

14.

Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine.

Guerkov RE, Targoni OS, Kreher CR, Boehm BO, Herrera MT, Tary-Lehmann M, Lehmann PV, Schwander SK.

J Immunol Methods. 2003 Aug;279(1-2):111-21.

PMID:
12969552
15.

Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.

Niemann S, Rüsch-Gerdes S, Joloba ML, Whalen CC, Guwatudde D, Ellner JJ, Eisenach K, Fumokong N, Johnson JL, Aisu T, Mugerwa RD, Okwera A, Schwander SK.

J Clin Microbiol. 2002 Sep;40(9):3398-405.

16.

Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community.

Schwander SK, Torres M, Carranza C C, Escobedo D, Tary-Lehmann M, Anderson P, Toossi Z, Ellner JJ, Rich EA, Sada E.

J Immunol. 2000 Aug 1;165(3):1479-85.

17.

Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy.

Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, Peters P, Ellner JJ.

J Infect Dis. 1999 Dec;180(6):2069-73.

PMID:
10558973
18.

Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis.

Schwander SK, Torres M, Sada E, Carranza C, Ramos E, Tary-Lehmann M, Wallis RS, Sierra J, Rich EA.

J Infect Dis. 1998 Nov;178(5):1434-45.

PMID:
9780265
19.

Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis.

Sadek MI, Sada E, Toossi Z, Schwander SK, Rich EA.

Am J Respir Cell Mol Biol. 1998 Sep;19(3):513-21.

PMID:
9730880
20.

Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.

Schwander SK, Dietrich M, Mugyenyi P, Kityo C, Okwera A, Johnson J, Nsubuga P, Ruesch-Gerdes S, Whalen C.

East Afr Med J. 1997 Sep;74(9):543-8.

PMID:
9487427
21.
22.

Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy.

Vanham G, Toossi Z, Hirsch CS, Wallis RS, Schwander SK, Rich EA, Ellner JJ.

Tuber Lung Dis. 1997;78(3-4):145-58. Review.

PMID:
9713647
23.

T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis.

Schwander SK, Sada E, Torres M, Escobedo D, Sierra JG, Alt S, Rich EA.

J Infect Dis. 1996 May;173(5):1267-72.

PMID:
8627084
24.

Alveolar macrophages as accessory cells for human gamma delta T cells activated by Mycobacterium tuberculosis.

Balaji KN, Schwander SK, Rich EA, Boom WH.

J Immunol. 1995 Jun 1;154(11):5959-68.

PMID:
7751639

Supplemental Content

Loading ...
Support Center